{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:49:09Z","timestamp":1790858949536,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.beha.2023.101448","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T06:42:44Z","timestamp":1676011364000},"page":"101448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA)"],"prefix":"10.1016","volume":"36","author":[{"given":"Jamie","family":"Stokke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Tann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader Kim","family":"El-Mallawany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilske","family":"Oschlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.beha.2023.101448_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2023.101448_bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world Health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.beha.2023.101448_bib3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2023.101448_bib4","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.2021012057","article-title":"Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC","volume":"140","author":"Olsen","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2023.101448_bib6","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1002\/cnr2.1473","article-title":"Classical Hodgkin's lymphoma with cutaneous involvement in an adolescent male: a case study","volume":"5","author":"Ghosh","year":"2022","journal-title":"Cancer reports (Hoboken, NJ)"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/PAS.0b013e3182487158","article-title":"Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma","volume":"36","author":"Eberle","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"16","key":"10.1016\/j.beha.2023.101448_bib8","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood.2019000933","article-title":"Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder","volume":"135","author":"Melani","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2023.101448_bib9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1182\/blood.2020007245","article-title":"Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma","volume":"137","author":"Shimada","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2023.101448_bib10","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1182\/blood-2007-07-100958","article-title":"Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study","volume":"111","author":"Le Deley","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.beha.2023.101448_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102747","article-title":"Prognostic factors in childhood anaplastic large cell lymphoma: long term results of the international ALCL99 trial","volume":"12","author":"Mussolin","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaad.2010.10.040","article-title":"Cutaneous B-cell lymphoblastic lymphoma in children: a rare diagnosis","volume":"66","author":"Boccara","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.beha.2023.101448_bib13","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jaad.2020.01.058","article-title":"Outcome and clinicophenotypical features of acute lymphoblastic leukemia\/lymphoblastic lymphoma with cutaneous involvement: a multicenter case series","volume":"83","author":"Bontoux","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.beha.2023.101448_bib14","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.0736-8046.2004.21500.x","article-title":"The spectrum of cutaneous lymphomas in patients less than 20 years of age","volume":"21","author":"Fink-Puches","year":"2004","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/pbc.25881","article-title":"Rare pediatric non-hodgkin lymphomas: a report from children's oncology group study ANHL 04B1","volume":"63","author":"O'Suoji","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.beha.2023.101448_bib17","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/pbc.26076","article-title":"Primary cutaneous lymphomas in children and adolescents","volume":"63","author":"Ceppi","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.beha.2023.101448_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/pbc.23103","article-title":"Cutaneous hematologic disorders in children","volume":"58","author":"Boccara","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.beha.2023.101448_bib19","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/jdv.13044","article-title":"Paediatric cutaneous lymphomas: a review and comparison with adult counterparts","volume":"29","author":"Kempf","year":"2015","journal-title":"J Eur Acad Dermatol Venereol : JEADV"},{"issue":"2","key":"10.1016\/j.beha.2023.101448_bib20","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2023.101448_bib21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/bjd.13440","article-title":"Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome","volume":"172","author":"Oschlies","year":"2015","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.beha.2023.101448_bib22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/pbc.24462","article-title":"Subcutaneous panniculitis-like T-cell lymphoma in the pediatric age group: a lymphoma of low malignant potential","volume":"60","author":"Huppmann","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"10.1016\/j.beha.2023.101448_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29285","article-title":"Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents","volume":"68","author":"Au-Yeung","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"10.1016\/j.beha.2023.101448_bib24","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.beha.2023.101448_bib25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/bloodadvances.2018028340","article-title":"Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma","volume":"3","author":"Polprasert","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib26","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/MPH.0000000000001954","article-title":"Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic lymphohistiocytosis syndrome in children and its essential role of HAVCR2 gene mutation analysis","volume":"43","author":"Chaweephisal","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"13","key":"10.1016\/j.beha.2023.101448_bib27","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/bloodadvances.2020001451","article-title":"Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification","volume":"4","author":"Yonese","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.beha.2023.101448_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1442-200X.2011.03369.x","article-title":"Six-year-old girl with primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma","volume":"53","author":"Kikuchi","year":"2011","journal-title":"Pediatr Int"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaad.2021.04.081","article-title":"Primary cutaneous T-cell lymphomas other than mycosis fungoides and S\u00e9zary syndrome. Part II: prognosis and management","volume":"85","author":"Oh","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/pde.12168","article-title":"Primary cutaneous CD4+ small to medium-size pleomorphic T-cell lymphoma in a 12-year-old girl","volume":"30","author":"Volks","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"10.1016\/j.beha.2023.101448_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29862","article-title":"Primary cutaneous CD4(+) small\/medium T-cell lymphoproliferative disorder in children: a case report and review of the literature","volume":"69","author":"Plumptre","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cup.13939","article-title":"Primary cutaneous follicle center lymphoma in a 16-year-old girl","volume":"48","author":"Edmonds","year":"2021","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjd.20973","article-title":"Clinical, histopathological and prognostic features of primary cutaneous acral CD8(+) T-cell lymphoma and other dermal CD8(+) cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop","volume":"186","author":"Kempf","year":"2022","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2021.04.080","article-title":"Primary cutaneous T-cell lymphomas other than mycosis fungoides and S\u00e9zary syndrome. Part I: clinical and histologic features and diagnosis","volume":"85","author":"Stoll","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/his.14556","article-title":"Cutaneous B cell lymphomas: standards in diagnostic and clinical work-up. Hints, pitfalls and recent advances","volume":"80","author":"Oschlies","year":"2022","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00428-019-02713-7","article-title":"The clinico-pathological spectrum of primary cutaneous lymphoma other than mycosis fungoides\/Sezary syndrome","volume":"476","author":"Oschlies","year":"2020","journal-title":"Virchows Arch : an international journal of pathology"},{"issue":"12","key":"10.1016\/j.beha.2023.101448_bib37","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101448_bib38","series-title":"Non-Hodgkin's lymphoma in childhood and adolescence","first-page":"281","article-title":"Cutaneous T-cell lymphomas in childhood and adolescence","author":"Willemze","year":"2019"},{"issue":"6","key":"10.1016\/j.beha.2023.101448_bib39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2009.05.014","article-title":"Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients","volume":"61","author":"de Souza","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.beha.2023.101448_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40257-016-0192-6","article-title":"Lymphomatoid papulosis in children and adolescents: a systematic review","volume":"17","author":"Wieser","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.beha.2023.101448_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151486","article-title":"Lymphomatoid papulosis in children and adolescents: a clinical and histopathologic retrospective cohort","volume":"46","author":"Georgesen","year":"2020","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"10.1016\/j.beha.2023.101448_bib42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archderm.140.3.306","article-title":"Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases","volume":"140","author":"Nijsten","year":"2004","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.beha.2023.101448_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228751","article-title":"Evidence linking atopy and staphylococcal superantigens to the pathogenesis of lymphomatoid papulosis, a recurrent CD30+ cutaneous lymphoproliferative disorder","volume":"15","author":"Kadin","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.beha.2023.101448_bib44","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1182\/blood.2019002799","article-title":"Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease","volume":"135","author":"Melchers","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib45","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/bjd.13061","article-title":"Lymphomatoid papulosis in children: a series of 25 cases","volume":"171","author":"Miquel","year":"2014","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.beha.2023.101448_bib46","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.beha.2023.101448_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hon.2584","article-title":"Cutaneous lymphomas-An update 2019","volume":"37","author":"Kempf","year":"2019","journal-title":"Hematol Oncol"},{"issue":"10","key":"10.1016\/j.beha.2023.101448_bib48","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/leu.2012.246","article-title":"EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations","volume":"26","author":"Langerak","year":"2012","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.beha.2023.101448_bib49","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.jid.2020.02.019","article-title":"Recurrent oncogenic JAK and STAT alterations in cutaneous CD30-positive lymphoproliferative disorders","volume":"140","author":"Maurus","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib50","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/bjd.13920","article-title":"Recommendations for treatment of lymphomatoid papulosis with methotrexate: a report from the Dutch Cutaneous Lymphoma Group","volume":"173","author":"Bruijn","year":"2015","journal-title":"Br J Dermatol"},{"issue":"15","key":"10.1016\/j.beha.2023.101448_bib51","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"issue":"32","key":"10.1016\/j.beha.2023.101448_bib52","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1200\/JCO.2014.60.3787","article-title":"Results of a phase II trial of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma and lymphomatoid papulosis","volume":"33","author":"Duvic","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.beha.2023.101448_bib53","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jamadermatol.2017.3593","article-title":"Brentuximab vedotin for patients with refractory lymphomatoid papulosis: an analysis of phase 2 results","volume":"153","author":"Lewis","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10024-004-8087-6","article-title":"Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature","volume":"8","author":"Kumar","year":"2005","journal-title":"Pediatr Dev Pathol"},{"issue":"3","key":"10.1016\/j.beha.2023.101448_bib55","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/pde.14585","article-title":"Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy","volume":"38","author":"Linggonegoro","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib56","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.beha.2023.101448_bib57","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/PAS.0000000000001449","article-title":"Clinical, histologic, and molecular characteristics of anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma","volume":"44","author":"Melchers","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.beha.2023.101448_bib58","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3324\/haematol.2020.263251","article-title":"Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma","volume":"107","author":"Bastidas Torres","year":"2022","journal-title":"Haematologica"},{"issue":"10094","key":"10.1016\/j.beha.2023.101448_bib59","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(17)31266-7","article-title":"Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial","volume":"390","author":"Prince","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.beha.2023.101448_bib60","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.136.4.504","article-title":"Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients","volume":"136","author":"van Doorn","year":"2000","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.beha.2023.101448_bib61","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/ddg.14509","article-title":"Primary cutaneous T-cell lymphomas in childhood and adolescence","volume":"19","author":"Wohlmuth-Wieser","year":"2021","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG"},{"issue":"10","key":"10.1016\/j.beha.2023.101448_bib62","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.11780","article-title":"Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study","volume":"98","author":"Wain","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.beha.2023.101448_bib63","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2013.12.029","article-title":"Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement","volume":"70","author":"Hodak","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.beha.2023.101448_bib64","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1097\/MPH.0000000000002354","article-title":"Pediatric mycosis fungoides: retrospective analysis of a series with CD8 + profile and female predominance","volume":"44","author":"Purnak","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.beha.2023.101448_bib65","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/pde.12338","article-title":"Childhood mycosis fungoides: experience of 28 patients and response to phototherapy","volume":"31","author":"Laws","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"10.1016\/j.beha.2023.101448_bib66","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/PAS.0000000000001093","article-title":"Pityriasis lichenoides, atypical pityriasis lichenoides, and related conditions: a study of 66 cases","volume":"42","author":"Borra","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.beha.2023.101448_bib67","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/cup.14143","article-title":"Next-generation sequencing confirms T-cell clonality in a subset of pediatric pityriasis lichenoides","volume":"49","author":"Raghavan","year":"2022","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.beha.2023.101448_bib68","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.beha.2023.101448_bib69","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamadermatol.2018.5204","article-title":"Comparison of narrowband UV-B with psoralen-UV-A phototherapy for patients with early-stage mycosis fungoides: a systematic review and meta-analysis","volume":"155","author":"Phan","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"15","key":"10.1016\/j.beha.2023.101448_bib70","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199704103361501","article-title":"Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study","volume":"336","author":"Stern","year":"1997","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.beha.2023.101448_bib71","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jaad.2011.04.004","article-title":"The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study","volume":"66","author":"Stern","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/pde.14026","article-title":"Mycosis fungoides in pediatric patients: clinical features, diagnostic challenges, and advances in therapeutic management","volume":"37","author":"Wu","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2015.09.033","article-title":"Guidelines for phototherapy of mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the United States Cutaneous Lymphoma Consortium","volume":"74","author":"Olsen","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.beha.2023.101448_bib74","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2008-07-077982","article-title":"Classification of lymphoid neoplasms: the microscope as a tool for disease discovery","volume":"112","author":"Jaffe","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2023.101448_bib75","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaad.2018.05.1243","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: clinical features, therapeutic approach, and outcome in a case series of 16 patients","volume":"79","author":"L\u00f3pez-Lerma","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.beha.2023.101448_bib76","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2478\/v10019-012-0017-z","article-title":"Usefulness of F-18 FDG PET\/CT in subcutaneous panniculitis-like T cell lymphoma: disease extent and treatment response evaluation","volume":"46","author":"Kim","year":"2012","journal-title":"Radiol Oncol"},{"issue":"13","key":"10.1016\/j.beha.2023.101448_bib77","first-page":"1058","article-title":"HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma","volume":"135","author":"Sonigo","year":"2020","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.beha.2023.101448_bib78","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1182\/bloodadvances.2021004562","article-title":"Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations","volume":"5","author":"Koh","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.beha.2023.101448_bib79","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2340\/00015555-2543","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: immunosuppressive drugs induce better response than polychemotherapy","volume":"97","author":"Michonneau","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib80","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s13023-022-02575-4","article-title":"A retrospective study of 18 children with subcutaneous panniculitis-like T-cell lymphoma: multidrug combination chemotherapy or immunomodulatory therapy?","volume":"17","author":"Duan","year":"2022","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.beha.2023.101448_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28416","article-title":"Rare non-Hodgkin lymphoma of childhood and adolescence: a consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma","volume":"67","author":"Attarbaschi","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.beha.2023.101448_bib82","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/bjd.13053","article-title":"Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma","volume":"171","author":"Guenova","year":"2014","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.beha.2023.101448_bib83","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/ejh.12439","article-title":"Gamma-delta t-cell lymphomas","volume":"94","author":"Foppoli","year":"2015","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.beha.2023.101448_bib84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fped.2019.00071","article-title":"Epstein-barr virus-associated T and NK-cell lymphoproliferative diseases","volume":"7","author":"Kim","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.beha.2023.101448_bib85","series-title":"Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting","first-page":"1","author":"Cohen","year":"2019"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjh.17638","article-title":"Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes","volume":"196","author":"El-Mallawany","year":"2022","journal-title":"Br J Haematol"},{"issue":"26","key":"10.1016\/j.beha.2023.101448_bib87","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.2018893750","article-title":"Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites","volume":"133","author":"Cohen","year":"2019","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.beha.2023.101448_bib88","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.beha.2023.101448_bib89","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5021\/ad.2021.33.3.222","article-title":"Hydroa vacciniforme-like lymphoproliferative disorder in Korea: prognostic implication of clinical signs and whole blood epstein-barr virus DNA","volume":"33","author":"Oh","year":"2021","journal-title":"Ann Dermatol"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76345-2","article-title":"Hydroa vacciniforme-like lymphoproliferative disorder in Korea","volume":"10","author":"Han","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.beha.2023.101448_bib91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.semdp.2019.12.004","article-title":"Epstein - Barr virus positive T and NK-cell lymphoproliferations: morphological features and differential diagnosis","volume":"37","author":"Montes-Mojarro","year":"2020","journal-title":"Semin Diagn Pathol"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692623000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692623000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:06:51Z","timestamp":1761498411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692623000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1521692623000099"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2023.101448","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA)","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2023.101448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101448"}}